The UnSeen,

     The UnCounted,

          The Undiagnosed Network

 

~

  "Conditions in society which are not defined as a problem and for which alternatives are never proposed, never become policy issues. Government does nothing and conditions remain the same."  T.R.Dye, Policy Analyst
(From the book "Understanding Public Policy"
 

To help us win the fight and to find out more click HERE

Home

Prisons-the Epicenter of Infectious Diseases

Native Americans

References

 

HCV Tables for Native Americans

 

Hepatitis-C Prevalence in an Urban Native-American Clinic

 
  HCV prevalence: total and by gender
           
      HCV Antibody   HCV RNA  
  Overal (%) n Prevalence (%) n Prevalence (%) n
Female 66.3% 161 8.1% 13 6.2% 10
Male 33.7% 82 18.3% 15 13.4% 11
Total 100.0% 243 11.5% 28 8.6% 21
           
Hepatitis-C Prevalence in an Urban Native-American Clinic: A Prospective Screening Study
by Amy S. Neumeister, MD; LaVada E. Pilcher; Judi M. Erickson, RN, BSN, CDE; Lora L. Langley RN, BSN;
Mary M. Murphy, APRN; Nicole M: Haukaas, RN, BSN; Mark E. Mailliard, MD; and Jennifer L. Larsen, MD
 

 

 

  HCV prevalence by age
      HCV Antibody  
Age Overal (%) n Prevalence (%) n
<29 24.3% 59 1.7% 1
30-39 18.5% 45 17.8% 8
40-49 30.9% 75 16.0% 12
50-59 17.3% 42 16.7% 7
> 60 9.0% 22 0.0% 0
       
Hepatitis-C Prevalence in an Urban Native-American Clinic: A Prospective Screening Study
by Amy S. Neumeister, MD; LaVada E. Pilcher; Judi M. Erickson, RN, BSN, CDE; Lora L. Langley RN, BSN;
Mary M. Murphy, APRN; Nicole M: Haukaas, RN, BSN; Mark E. Mailliard, MD; and Jennifer L. Larsen, MD

 

 

 

 
 
Risk factors by HCV status (prospective screening)
   
Factor HCV Positive HCV Negative
Male 52.4% 31.2%
Infravenous drug or cocaine use 66.7% 25.6%
Old tatoos (>5 years) 38.1% 8.8%
Sexual partner with hepatitis C 19.0% 2.3%
Alcoholism* 42.9% 21.4%
Any transusion 38.1% 17.2%
Any tattoos 81.0% 56.7%
Blood transfusion before 1992 23.8% 10.7%
   
*Alcoholism is defined by self-admission or an affirmative response to > CAGE question
   
Hepatitis-C Prevalence in an Urban Native-American Clinic: A Prospective Screening Study
by Amy S. Neumeister, MD; LaVada E. Pilcher; Judi M. Erickson, RN, BSN, CDE; Lora L. Langley RN, BSN;
Mary M. Murphy, APRN; Nicole M: Haukaas, RN, BSN; Mark E. Mailliard, MD; and Jennifer L. Larsen, MD

 

Epidemiology and Risk Factors for Hepatitis C in Alaska Natives by
Brian J. McMahon, Thomas W. Hennessy, Carol Christensen, Dana Bruden, Daniel G. Sullivan, Chriss Homan,
Heike Deubner, Michael G. Bruce, Stephen Livingston, James Williams, and David R. Gretch
     
The Proportion of Alaska Natives -Enrolled in the Cohort Who

Were Hepatitis C Virus RNA-Positive,

According to Characteristics and Risk Factors (N = 701)
       
  % Hepatitis C    
Characteristic Virus RNA+   n
Gender      
     Male 77.5   381
    Female 69.6   320
Location      
     Rural 76.1   230
     Urban 71.7   471
Risk factor      
     Blood transfusion 86.7   98
     Intravenous drug user 69.5   423
     All others 75.0   172
Age at estimated infection date (yrs)      
     <20 75.2   157
     20-29 68.8   250
     30-39 72.2   126
     40+ 84.6   39
Abbreviations: RT-PCR, reverse-transcription polymerase chain reaction; PCR, polymerase chain reaction.
* P value comparing percent RT-PCR-positive rate for all three goups was <0.01.  Pvalue comparing percent 
       PCR-positive for intravenous drug users vs. others was 0.18. P-value comparing percent PCR-positive for
       blood transfusion participants versus all others combine was ,0.01    
**Odds of a participant bening PCR positive if their risk factor is a blood transfusion versus the odds for all 
      other groups combined      
***P value comparing percent PCR-positive if they were more than 40 years of age at estimated date of infection
      compared with if they were younger than 40 years of age    
****Odds of a participant being PCR positive if they were estimated to have been infected before 1970 
     compared with after 1969